Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing
2017 · Clinical Cancer Research · 561 citations
https://doi.org/10.1158/1078-0432.ccr-17-0577
C
Congying Xie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
288
Papers
4.3K
Citations
34
h-index
99
i10-index
Congying Xie is an academic researcher from Mount Sinai Beth Israel. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Advanced Radiotherapy Techniques. The author has an h-index of 34, co-authored 245 publications.
ORCID: 0000-0002-1693-9034Papers by this author
worksSub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy
2019 · EBioMedicine · 163 citations
https://doi.org/10.1016/j.ebiom.2019.05.023
Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a
2020 · Aging · 93 citations
https://doi.org/10.18632/aging.103136
Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells
2015 · Stem Cell Research & Therapy · 90 citations
https://doi.org/10.1186/s13287-015-0076-3
Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling
2020 · Cell Death and Disease · 84 citations
https://doi.org/10.1038/s41419-020-02778-2
MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21
2016 · Cancer Medicine · 63 citations
https://doi.org/10.1002/cam4.863
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat